KAD Arcadia Resources Common Stock

The home healthcare sector was hardly a factor in the two-year market rally as many in the industry have yet to recover to pre-recession levels. High unemployment has led to fewer people being able to afford health care. In addition, the number of family members not working and therefore unable to provide care to those that need it has increased. The Bedford Report examines the outlook for companies in the Home Health Care Industry and provides research reports on Arcadia Resources, Inc. (NYSE Amex: KAD) and Lincare Holdings, Inc. (NASDAQ: LNCR). Access to the full company reports can be found at:

www.bedfordreport.com/2011-03-KAD

www.bedfordreport.com/2011-03-LNCR

Medical service companies could be a possible target for reductions as Republicans in Congress seek ways to cut billions from the federal budget. Medicare spending is the largest single component of federal outlays. Lincare provides respiratory therapy and other services to patients in their homes. According to a recent federal budget report oxygen therapy companies are among government healthcare vendors that are overpaid and should have reimbursements cut. According to the Government Accountability Office Medicare pays oxygen companies 44 percent more than what it costs them to provide services.

The Bedford Report releases regular market updates on the Home Health Care Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.

In the fourth quarter of 2010, Lincare posted net income of $46.1 million, or 48 cents a share, on revenue of $422.1 million. In the same period a year earlier, the company reported net income of $40.6 million, or 41 cents a share, on revenue of $405.8 million.

Last month Arcadia Resources announced fiscal 2011 third quarter net revenues of $26.2 million and a consolidated net loss of $2.3 million, or $0.01 per share. Arcadia has been expanding its DailyMed pharmacy program into the state of Kansas. The DailyMed program delivers monthly doses of a customer's medication to their homes. For its most recent quarter Arcadia says its DailyMed active patient count improved 21 percent sequentially.

The Bedford Report provides Analyst Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.bedfordreport.com/disclaimer

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact: The Bedford Report Email Contact